Glow LifeTech Corp. GLWLF GLOW (FSE:9DO) announced the upcoming launch of multiple in-house cannabis consumer brands powered by its portfolio of proprietary ingredient technologies. The company expects to commercially deploy its products into the Canadian cannabis market as early as Q3 2023.
"By launching our own in-house CPG brands and products, we are able to expedite the route to market for our proprietary ingredients and ensure an optimal consumer experience, all while demonstrating the success of our technologies in one the largest cannabis markets in the world," stated Rob Carducci, chief commercial officer, Glow LifeTech. "We have multiple avenues for value creation and CPG products unlock a new vehicle to build the B2B business, by showcasing our technology in real-world settings and adding additional brand and formulation IP that can be licensed around the world."
Technology Platform
Glow has built a technology platform that allows the company to support a variety of product formats including drops, sprays, capsules, drink mixes, gummies, infused-foods, and more. The company has developed a proprietary, water-soluble cannabis powder technology, which expands the company's technology portfolio to both liquid and powder cannabinoid ingredients, building on its existing liquid MyCell Technology. Glow's portfolio of water-soluble cannabis ingredients includes THC, CBD, CBN and CBG.
The company has built an asset-light cannabis production operation with a factor-in-factory manufacturing partnership in Toronto, Canada, that is designed to scale and minimize operating costs. With the processing facility built and equipment commissioned, it will house all of Glow's cannabis-related R&D activities, serving as the company's cannabis production center to develop technologies and products for the global market. This single licensed production location provides the company the necessary production capacity to produce a diverse portfolio of cannabis products to service the Canadian market nationally, across both adult-use and medical cannabis markets.
Benzinga Cannabis Capital Conference
The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.
Photo by Esteban López on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry? Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.